• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Moustafa, D. (2021). HIF-1α & NF-κB Downregulation by S-Carvone Mitigate Hypoxia and Inflammation in CoCl2 Treated Cells. Journal of Advanced Pharmacy Research, 5(4), 398-405. doi: 10.21608/aprh.2021.85254.1137
Dina Moustafa. "HIF-1α & NF-κB Downregulation by S-Carvone Mitigate Hypoxia and Inflammation in CoCl2 Treated Cells". Journal of Advanced Pharmacy Research, 5, 4, 2021, 398-405. doi: 10.21608/aprh.2021.85254.1137
Moustafa, D. (2021). 'HIF-1α & NF-κB Downregulation by S-Carvone Mitigate Hypoxia and Inflammation in CoCl2 Treated Cells', Journal of Advanced Pharmacy Research, 5(4), pp. 398-405. doi: 10.21608/aprh.2021.85254.1137
Moustafa, D. HIF-1α & NF-κB Downregulation by S-Carvone Mitigate Hypoxia and Inflammation in CoCl2 Treated Cells. Journal of Advanced Pharmacy Research, 2021; 5(4): 398-405. doi: 10.21608/aprh.2021.85254.1137

HIF-1α & NF-κB Downregulation by S-Carvone Mitigate Hypoxia and Inflammation in CoCl2 Treated Cells

Article 5, Volume 5, Issue 4, October 2021, Page 398-405  XML PDF (518.82 K)
Document Type: Research Article
DOI: 10.21608/aprh.2021.85254.1137
View on SCiNiTO View on SCiNiTO
Author
Dina Moustafa email
Department of Pharmacology and Toxicology, Faculty of Pharmacy, October 6 University, 6 October City, 12566, Giza, Egypt
Abstract
Background: S-CAV is a natural monoterpene that possesses antioxidant, anti-inflammatory, and anticancer activities. Both HIF and NF-κB pathways play a role in the hypoxia and inflammation during cancer progression. Objectives: In this study, we determine the effect of S-CAV against hypoxia-induced by CoCl2 on A549 cells through the relationship between HIF-1α and NF-κB as well as inflammatory cytokines and oxidative stress. Methods: A549 cells were treated with S-CVN and CoCl2 either alone or in combination for 24 hours. Afterward, cytotoxicity, cell viability, and mode of cell death were determined. Different markers were measured to detect the effect of S-CVN on CoCl2 induced oxidative damage (MDA and TAC), hypoxia associated inflammation (IL-6 and TNF-α), as well as HIF-1α and NF-κB gene expression. Results: The results showed that S-CAV and CoCl2 induced cytotoxicity at concentrations 4 and 6.2 mM. S-CAV and CoCl2 combination therapy showed apoptotic cell death and a reduction in oxidative stress markers. Moreover, S-CAV in combination therapy downregulates the mRNA HIF-1α and NF-κB expression that parallels the reduction in IL-6 and TNF-α levels. Conclusion: Therefore, S-CAV possesses an antihypoxic effect on A549 CoCl2 treated cells by reducing the oxidative stress, HIF-1α, and NF-κB gene expression as well as proinflammatory cytokines. 
Keywords
Hypoxia; S-CAV; HIF-1α; CoCl2
Main Subjects
Section D: Clinical Pharmacy & Pharmacology
Statistics
Article View: 281
PDF Download: 407
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.